drugset / Trial / NCT07187037

Methylprednisolone vs Dexamethasone: Effects on Sugammadex Reversal, Pain, and Nausea in Adults

NCT07187037

Not yet recruiting 130 enrolled Konya City Hospital
RandomizedParallel-groupQuadruple-blindOther

Summary

This randomized controlled trial aims to compare the effects of intravenous methylprednisolone and dexamethasone on the reversal time of rocuronium by sugammadex in adult patients undergoing elective septoplasty or rhinoplasty. The primary outcome is the time from sugammadex administration to recovery of a train-of-four (TOF) ratio of 0.9. Secondary outcomes include extubation time, postoperative nausea and vomiting (PONV), pain scores, complications in the post-anesthesia care unit (PACU), and intraoperative hemodynamic parameters. The study will provide new evidence on whether perioperative corticosteroid choice modifies the efficacy of sugammadex and influences postoperative recovery.

Timeline

Start
2025-10-01
Primary completion
2026-04-30
Completion
2026-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 0.2 mg/kg Intravenous
Comparator Methylprednisolone Other / unclassified 1 mg/kg Intravenous